Jan Kaiserle

Jan Kaiserle

Medical Systems Advisor
Jan Kaiserle specializes in medical research and evidence-based medicine. He explores the latest advancements in medical science, clinical trials, and healthcare technologies to improve diagnosis, treatment, and disease prevention. His content bridges the gap between clinical research and practice, providing meaningful insights for healthcare professionals.
New ADC Shows High Efficacy in Two Deadly Blood Cancers
Tech & Innovation New ADC Shows High Efficacy in Two Deadly Blood Cancers

The ongoing battle against highly aggressive blood cancers has reached a pivotal moment with the emergence of a groundbreaking therapy that demonstrated remarkable effectiveness in recent clinical trials. Comprehensive data presented at the 67th American Society of Hematology (ASH) Annual Meeting

Can a Safer Melanoma Treatment Also Be More Effective?
Research & Development Can a Safer Melanoma Treatment Also Be More Effective?

In the world of oncology, the conventional wisdom has often been to hit cancer as hard as possible. But a groundbreaking study on immunotherapy for malignant melanoma is challenging that paradigm, suggesting that sometimes, less is more. We sit down with biopharma expert Ivan Kairatov to dissect

PTSD Accelerates Brain Aging in 9/11 Responders
Tech & Innovation PTSD Accelerates Brain Aging in 9/11 Responders

More than two decades after the tragic events of September 11, 2001, the enduring health consequences for the heroic first responders continue to unfold, revealing wounds far deeper than those visible to the naked eye. A landmark study has now cast a powerful light on one of the most insidious of

How Does a Protein Network Stabilize ABCC4 for cAMP Control?
Research & Development How Does a Protein Network Stabilize ABCC4 for cAMP Control?

Allow me to introduce Ivan Kairatov, a distinguished biopharma expert whose innovative research and development work has significantly advanced our understanding of cellular signaling and protein interactions. With a profound focus on transporter regulation, Ivan has been at the forefront of

Lilly Pushes Jaypirca for Wider Use in Leukemia at ASH
Research & Development Lilly Pushes Jaypirca for Wider Use in Leukemia at ASH

Imagine a world where a single drug could shift the trajectory of blood cancer treatment, offering hope to thousands battling chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). At the recent American Society of Hematology (ASH) meeting in Orlando, Eli Lilly thrust its BTK

Sweat Testing: A Game-Changer for Diagnostics and Monitoring
Tech & Innovation Sweat Testing: A Game-Changer for Diagnostics and Monitoring

As I sit down with Ivan Kairatov, a renowned biopharma expert with a passion for cutting-edge technology and innovation, I’m eager to dive into the transformative potential of sweat as a diagnostic biofluid. With years of experience in research and development, Ivan has been at the forefront of

C-COMPASS Makes Spatial Omics Accessible to Non-Coders
Tech & Innovation C-COMPASS Makes Spatial Omics Accessible to Non-Coders

Imagine a world where the intricate dance of proteins and lipids within cells can be mapped and understood by any scientist, regardless of their technical background. Spatial omics, a field dedicated to pinpointing the locations of these critical molecules in tissues, holds the key to unraveling

DAX Transducer Revolutionizes Deep Ultrasound Imaging
Tech & Innovation DAX Transducer Revolutionizes Deep Ultrasound Imaging

Imagine a world where medical imaging struggles to keep up with the needs of an increasingly diverse patient population, leaving clinicians frustrated and diagnoses uncertain in challenging cases. For too long, ultrasound technology has faced significant hurdles when scanning patients with high

Medical Cannabis Lacks Evidence for Most Health Claims
Research & Development Medical Cannabis Lacks Evidence for Most Health Claims

What if a remedy hailed as a breakthrough for countless ailments turns out to be more myth than medicine? Across the U.S. and Canada, millions have turned to medical cannabis, hoping for relief from chronic pain, anxiety, and more. Yet, beneath the buzz, a sobering reality emerges: scientific

How Is FDA Shifting to Human-Relevant Drug Safety Models?
Biotech & Bioprocessing How Is FDA Shifting to Human-Relevant Drug Safety Models?

Imagine a world where life-saving drugs reach patients faster, with fewer animals harmed and costs slashed by millions. This isn’t a distant dream but a tangible goal as the U.S. Food and Drug Administration (FDA) pivots toward human-relevant drug safety models. With new draft guidance released

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later